Manipal Health Enterprises IPO to Open July 29 with Rs 560–590 Price Band; Listing Expected August 5
Key Takeaways
- •Manipal Health Enterprises' Rs 9,275-crore IPO opens for subscription on July 29, 2025, with shares priced between Rs 560 and Rs 590 each.
- •The offering consists of a Rs 8,000-crore fresh issue and a Rs 1,275.2-crore Offer for Sale component, with listing expected on August 5, 2025.
- •Grey market premium indications suggest approximately 10% listing gains, though GMP is an unofficial and non-guaranteed predictor of listing performance.
- •Temasek, the Singapore government's investment arm, is a key investor in Manipal Health Enterprises, which competes with listed peers such as Apollo Hospitals, Fortis Healthcare, and Max Healthcare.
- •The IPO comes as India's hospital industry expands due to rising healthcare spending, growing medical tourism, and increasing tertiary care demand in tier-2 and tier-3 cities.
Manipal Health Enterprises, the Bengaluru-based hospital chain backed by Singapore's Temasek and promoter Ranjan Pai, is set to open its Rs 9,275-crore initial public offering for subscription on July 29, 2025. The IPO carries a price band of Rs 560–590 per share.
The offering comprises a fresh issue of Rs 8,000 crore and an Offer for Sale (OFS) component amounting to Rs 1,275.2 crore. The shares are expected to list on stock exchanges on August 5. The issue ranks among the larger healthcare sector IPOs in India in recent years, coming at a time when the country's hospital industry continues to expand on the back of rising healthcare spending, growing medical tourism, and increasing demand for tertiary care across tier-2 and tier-3 cities.
Grey Market Premium
The title references grey market premium (GMP) indications of approximately 10% listing gains. GMP is the price at which IPO shares trade in the unofficial grey market before their formal listing on exchanges. It is widely tracked by investors as an informal indicator of listing-day sentiment, though it is not an official or guaranteed predictor of listing performance.
IPO Structure
The fresh issue portion of Rs 8,000 crore will inject new capital into the company, typically used for purposes such as debt repayment, capital expenditure, or general corporate purposes as disclosed in the IPO prospectus. The OFS component of Rs 1,275.2 crore involves existing shareholders selling a portion of their holdings, with the proceeds going to the selling shareholders rather than the company.
Company Background
Manipal Health Enterprises operates one of India's prominent private hospital networks, headquartered in Bengaluru. The chain is part of the broader Manipal Group, a diversified conglomerate with interests spanning healthcare, education, and research. Temasek, the Singapore government's investment arm, is a key investor in the company. Manipal competes with listed peers such as Apollo Hospitals, Fortis Healthcare, and Max Healthcare, all of which have reported sustained growth in patient volumes and revenues in recent quarters.
Key Dates and Details
| Detail | Information |
|---|---|
| IPO Size | Rs 9,275 crore |
| Price Band | Rs 560–590 per share |
| Fresh Issue | Rs 8,000 crore |
| Offer for Sale | Rs 1,275.2 crore |
| Subscription Opens | July 29, 2025 |
| Expected Listing Date | August 5, 2025 |
Source: Economic Times Markets
